PI3K delta inhibitor (unnamed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PI3K delta inhibitor (unnamed), covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy [Phase 1]